Observational studyAfrican health sciences2025
Value of cerebrovascular hemodynamics and thromboelastogram-related parameters in evaluating the effect of Naomai Jiejing Decoction on the rehabilitation of patients with aneurysmal subarachnoid hemorrhage.
Observational study in African health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: To explore the value of cerebrovascular hemodynamic and thromboelastogram-related parameters in evaluating the effect of Naomai Jiejing Decoction (NJD) on the rehabilitation of patients with Aneurysmal subarachnoid hemorrhage (aSAH). Methodology: This article is observational studies. This study compared cerebrovascular hemodynamics, thromboelastogram results, and rehabilitation outcomes between a research group (treated with Naomai Jiejing Decoction) and a control group (not treated with Naomai Jiejing Decoction) of 160 patients with Aneurysmal subarachnoid hemorrhage. Logistic regression analysis explored associations between poor rehabilitation outcomes and hemodynamic/thromboelastogram-related parameters in the research group. Results: At 12 months after operation, the measured hemodynamics values were lower in research group than those in control group, and the differences were statistically significant (P<0.05). Patients with good rehabilitation outcomes had lower measured hemodynamics values than those with poor rehabilitation outcomes. The results of Logistic regression analysis showed that the high values in hemodynamics and thromboelastogram examinations were risk factors for poor rehabilitation outcomes in research group (P<0.05). Conclusion: Monitoring cerebrovascular hemodynamic and thromboelastogram-related parameters in patients with Aneurysmal subarachnoid hemorrhage receiving Naomai Jiejing Decoction treatment can offer valuable prognostic and therapeutic insights, with improvements correlating to better rehabilitation outcomes, underscoring their significance in assessing intervention effectiveness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.